phase readout
saveNCT07518043: A Study of HLX18 vs. OPDIVO® in Multiple Resected Solid Tumors
NOT_YET_RECRUITINGupdated 1mo ago
community read0 votes
Sponsor: Shanghai Henlius Biotech. Phase: PHASE1. Conditions: Esophageal and/or Cardia Cancer, Melanoma, Urothelial Carcinoma (UC)
view source ↗
comments(0)
5-min edit window · permanent after that